Thirty Madison

Thirty Madison

Thirty Madison

In August 2020, JJDC invested in Thirty Madison, a leading digital health company, representing our commitment to help progress the development and delivery of healthcare solutions that aim to improve the experience of an estimated 133 million Americans living with chronic conditions.

Through the relationship with Thirty Madison, we’re aiming to bring the company’s digital-first, integrated health platform to new chronic conditions, with an intent to scale a care model that puts the patient first, democratize access to and affordability of specialty care, and ensure that patients get the right treatment at the right time.

Our collaboration with Johnson & Johnson Innovation has accelerated both the delivery of our care model and our ability to reach more patients. It has helped us provide high-impact, affordable, and accessible specialty care to our patients — and it’s working. We hear from our patients every day that our services have positively impacted their lives for the better.

Steven Gutentag
CEO and Co-Founder, Thirty Madison